WealthPlan Investment Management LLC Decreases Stock Position in Danaher Co. (NYSE:DHR)

WealthPlan Investment Management LLC lessened its stake in Danaher Co. (NYSE:DHR) by 2.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 25,688 shares of the conglomerate’s stock after selling 748 shares during the period. WealthPlan Investment Management LLC’s holdings in Danaher were worth $5,897,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in DHR. Heck Capital Advisors LLC purchased a new stake in Danaher in the 4th quarter worth $27,000. Decker Retirement Planning Inc. purchased a new stake in shares of Danaher in the 4th quarter worth approximately $31,000. Golden State Wealth Management LLC purchased a new stake in shares of Danaher during the fourth quarter valued at about $31,000. Teachers Insurance & Annuity Association of America acquired a new position in Danaher during the 3rd quarter valued at about $39,000. Finally, MidAtlantic Capital Management Inc. purchased a new position in Danaher in the 3rd quarter worth $40,000. Institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 11.10% of the company’s stock.

Danaher Stock Performance

NYSE:DHR opened at $206.66 on Friday. The firm’s 50-day moving average is $230.00 and its 200-day moving average is $249.96. Danaher Co. has a 52-week low of $196.80 and a 52-week high of $281.70. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The company has a market cap of $149.26 billion, a price-to-earnings ratio of 39.14, a PEG ratio of 2.68 and a beta of 0.83.

Danaher (NYSE:DHR) last announced its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter last year, the business earned $2.09 EPS. Equities research analysts anticipate that Danaher Co. will post 7.67 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were issued a dividend of $0.27 per share. The ex-dividend date was Friday, December 27th. This represents a $1.08 annualized dividend and a yield of 0.52%. Danaher’s dividend payout ratio is presently 20.45%.

Analysts Set New Price Targets

A number of brokerages recently issued reports on DHR. Jefferies Financial Group lowered their price target on shares of Danaher from $285.00 to $260.00 and set a “buy” rating on the stock in a report on Wednesday, January 29th. Raymond James reaffirmed a “market perform” rating on shares of Danaher in a research note on Monday, February 3rd. TD Cowen boosted their price target on shares of Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. Guggenheim assumed coverage on Danaher in a research report on Thursday, December 19th. They issued a “buy” rating and a $275.00 target price on the stock. Finally, UBS Group decreased their price target on Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a research note on Wednesday, October 23rd. Seven investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and an average target price of $278.00.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.